These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9921326)

  • 1. Different approaches to modelling the cost-effectiveness of schistosomiasis control.
    Guyatt H
    Mem Inst Oswaldo Cruz; 1998; 93 Suppl 1():75-84. PubMed ID: 9921326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different approaches to modeling the cost-effectiveness of schistosomiasis control.
    Guyatt HL; Tanner M
    Am J Trop Med Hyg; 1996 Nov; 55(5 Suppl):159-64. PubMed ID: 8940970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination or mass drug administration against schistosomiasis: a hypothetical cost-effectiveness modelling comparison.
    Collyer BS; Turner HC; Hollingsworth TD; Keeling MJ
    Parasit Vectors; 2019 Oct; 12(1):499. PubMed ID: 31647019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlling schistosomiasis: the cost-effectiveness of alternative delivery strategies.
    Guyatt H; Evans D; Lengeler C; Tanner M
    Health Policy Plan; 1994 Dec; 9(4):385-95. PubMed ID: 10139471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost analysis of schistosomiasis.
    Bundy DA; Guyatt HL
    Trans R Soc Trop Med Hyg; 1992; 86(6):646-8. PubMed ID: 1287932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact and cost-effectiveness of snail control to achieve disease control targets for schistosomiasis.
    Lo NC; Gurarie D; Yoon N; Coulibaly JT; Bendavid E; Andrews JR; King CH
    Proc Natl Acad Sci U S A; 2018 Jan; 115(4):E584-E591. PubMed ID: 29301964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cost-effectiveness of comprehensive schistosomiasis control strategy with focus on cattle and sheep removal in Junshan District, Yueyang City].
    Ya Y; Jian-Bing L; Hao L; Shi-Gui L; Zhong H; Bin C; Lin-Han L; Wan-Ting C; Yu Y; Jie Z; Zhi-Yang L; Guang-Hui R; Zhi-Hong L; Yi-Biao Z; Qing-Wu J
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2017 Dec; 30(1):14-17. PubMed ID: 29536700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cost-effectiveness evaluation on comprehensive control measures carrying out in schistosomiasis endemic areas with regard to different layers of administrative villages stratified by infection situation of human and domestic animals. I. Cost-effectiveness study in inner embankment of marshland and lake regions from 2006 to 2010].
    Zhang HM; Yu Q; Zhang X; Coa CL; Li SZ; Zhu H
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2014 Jun; 26(3):254-9. PubMed ID: 25345148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desirable characteristics of a schistosomiasis vaccine: some implications of a cost-effectiveness analysis.
    Guyatt HL; Evans D
    Acta Trop; 1995 Jun; 59(3):197-209. PubMed ID: 7572426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness analysis of the impacts on infection and morbidity attributable to three chemotherapy schemes against Schistosoma japonicum in hyperendemic areas of the Dongting Lake region, China.
    Yu D; Sarol JN; Hutton G; Tan D; Tanner M
    Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):441-57. PubMed ID: 12693575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Cost-effectiveness evaluation on comprehensive control measures carrying out in schistosomiasis endemic areas with regard to different layers of administrative villages stratified by infection situation of human and domestic animals. II Correlation analysis of costs and inputs with changes of schistosomiasis endemic situation in inner embankment of marshland and lake regions from 2006 to 2013].
    Hu HH; Yu Q; Zhang X; Cao CL; Li SZ; Zhu H
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2015 Feb; 27(1):17-21. PubMed ID: 26094407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human behaviour, cost-effectiveness analysis and research and development priorities: the case of a schistosomiasis vaccine.
    Evans DB; Guyatt HL
    Trop Med Int Health; 1997 Nov; 2(11):A47-54. PubMed ID: 9391522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of global guidelines for preventive chemotherapy against schistosomiasis and soil-transmitted helminthiasis: a cost-effectiveness modelling study.
    Lo NC; Lai YS; Karagiannis-Voules DA; Bogoch II; Coulibaly JT; Bendavid E; Utzinger J; Vounatsou P; Andrews JR
    Lancet Infect Dis; 2016 Sep; 16(9):1065-1075. PubMed ID: 27286968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cost-effectiveness and cost-benefit analysis on the integrated schistosomiasis control strategies with emphasis on infection source in Poyang Lake region].
    Lin DD; Zeng XJ; Chen HG; Hong XL; Tao B; Li YF; Xiong JJ; Zhou XN
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2009 Aug; 27(4):297-302. PubMed ID: 20066982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The control of helminths: nonreplicating infectious agents of man.
    Warren KS
    Annu Rev Public Health; 1981; 2():101-5. PubMed ID: 6890842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Performance of detection and treatment in schistosomiasis in Hubei Province, 2011].
    Pi WL; Tan XD; Di J; Deng Y; Jiang BJ
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2013 Aug; 25(4):405-7. PubMed ID: 24358753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the epidemiological impact of national control programmes for helminths.
    Brooker S; Whawell S; Kabatereine NB; Fenwick A; Anderson RM
    Trends Parasitol; 2004 Nov; 20(11):537-45. PubMed ID: 15471706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of community-wide, integrated mass drug administration strategies for schistosomiasis and soil-transmitted helminthiasis: a cost-effectiveness modelling study.
    Lo NC; Bogoch II; Blackburn BG; Raso G; N'Goran EK; Coulibaly JT; Becker SL; Abrams HB; Utzinger J; Andrews JR
    Lancet Glob Health; 2015 Oct; 3(10):e629-38. PubMed ID: 26385302
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.